gsk2269557
Showing 1 - 4 of 4
Pulmonary Disease, Chronic Obstructive Trial in Canada, Denmark (GSK2269557, Placebo, DISKUS)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- +3 more
-
Vancouver, British Columbia, Canada
- +5 more
Aug 12, 2021
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK2269557, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- Placebo
-
Edegem, Belgium
- +16 more
Aug 11, 2021
Asthma Trial in London (GSK2269557, GSK2269557 matching )
Completed
- Asthma
- GSK2269557
- GSK2269557 matching placebo
-
London, United KingdomGSK Investigational Site
Jul 24, 2017
Pulmonary Disease, Chronic Obstructive Trial in London (GSK2269557, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- Placebo
-
London, United KingdomGSK Investigational Site
Jul 10, 2017